Citation: Tr. Spitzer et al., ANTIEMETIC STRATEGIES FOR HIGH-DOSE CHEMORADIOTHERAPY-INDUCED NAUSEA AND VOMITING, Supportive care in cancer, 6(3), 1998, pp. 233-236
Authors:
ROILA F
DELFAVERO A
GRALLA RJ
TONATO M
AAPRO MS
ANDREWS PLR
BALLATORI E
DEMULDER PHM
DICATO MA
DUBOIS A
FEYER PC
GANDARA DR
GRALLA RJ
GRALLA RJ
GROSHEN S
GRUNBERG SM
HERRSTEDT J
HESKETH PJ
JOSS RA
KRIS MG
MARTY MM
MORROW GR
NAYLOR RJ
OLVER IN
SMYTH JF
SPITZER TR
STEWART A
Citation: F. Roila et al., PREVENTION OF CHEMOTHERAPY-INDUCED AND RADIOTHERAPY-INDUCED EMESIS - RESULTS OF THE PERUGIA CONSENSUS CONFERENCE, Annals of oncology, 9(8), 1998, pp. 811-819
Authors:
COLBY C
MCAFEE SL
FINKELSTEIN DM
SPITZER TR
Citation: C. Colby et al., EARLY VS DELAYED ADMINISTRATION OF G-CSF FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21(10), 1998, pp. 1005-1010
Authors:
HAYES GB
MARK EJ
MCLOUD TC
AMREIN PC
SPITZER TR
Citation: Gb. Hayes et al., A 51-YEAR-OLD MAN WITH MYELODYSPLASIA AND A PULMONARY INFILTRATE - MYELODYSPLASTIC SYNDROME (REFRACTORY-ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION), WITH IMMATURE MYELOID CELLS INFILTRATING THE LUNGS - DESQUAMATIVE INTERSTITIAL PNEUMONITIS, The New England journal of medicine, 338(7), 1998, pp. 453-461
Citation: Sg. Terra et al., A REVIEW OF TISSUE-PLASMINOGEN ACTIVATOR IN THE TREATMENT OF VENOOCCLUSIVE LIVER-DISEASE AFTER BONE-MARROW TRANSPLANTATION, Pharmacotherapy, 17(5), 1997, pp. 929-937
Authors:
SPITZER TR
MCAFEE SL
SAIDMAN S
WEYMOUTH D
PREFFER F
OLSON D
COLBY C
SACHS DH
SYKES M
Citation: Tr. Spitzer et al., CLINICAL REMISSION OF REFRACTORY NON-HODGKINS-LYMPHOMA INDUCED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) WITH MIXED CHIMERISM NON-MYELOABLATED RECIPIENTS, Blood, 90(10), 1997, pp. 1856-1856
Citation: C. Colby et al., ANTITHYMOCYTE IMMUNOGLOBULIN IN SEVERE APLASTIC-ANEMIA AND BONE-MARROW TRANSPLANTATION, The Annals of pharmacotherapy, 30(10), 1996, pp. 1164-1174
Authors:
ESTEVALORENZO FJ
MEEHAN KR
SPITZER TR
MAZUMDER A
Citation: Fj. Estevalorenzo et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A PATIENT WITH HYPEREOSINOPHILIC SYNDROME, American journal of hematology, 51(2), 1996, pp. 164-165
Citation: Ra. Cahill et al., MARROW ENGRAFTMENT AND CLINICAL MANIFESTATIONS OF CAPILLARY LEAK SYNDROME, Bone marrow transplantation, 18(1), 1996, pp. 177-184
Authors:
ARUNKILIC B
SPITZER TR
RAJAGOPAL C
MCAFEE S
LIPPMAN ME
MAZUMDER A
MEEHAN KR
Citation: B. Arunkilic et al., SURVIVAL FOR STAGE IIIB BREAST-CANCER FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION(PBSCT), Blood, 88(10), 1996, pp. 498-498
Authors:
SPITZER TR
SCAVONE M
BROWN C
MCAFEE SL
OLSZAK I
PREFFER F
Citation: Tr. Spitzer et al., ALTERATIONS OF PLASMA CYTOKINE LEVELS AND T-CELL SUBSET REGENERATION FOLLOWING INTRAVENOUS IMMUNOGLOBULIN (IVIG) ADMINISTRATION AND ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 1656-1656
Authors:
SPITZER TR
CIRENZA E
MCAFEE S
FOELBER R
ZARZIN J
CAHILL R
MAZUMDER A
Citation: Tr. Spitzer et al., PHASE I-II TRIAL OF HIGH-DOSE CYCLOPHOSPHAMIDE, CARBOPLATIN AND AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD STEM-CELL RESCUE, Bone marrow transplantation, 15(4), 1995, pp. 537-542
Authors:
SPITZER TR
BRYSON JC
CIRENZA E
FOELBER R
WALLERSTADT M
STOUT C
KUNKA RL
PLAGGE PB
DUBOIS A
Citation: Tr. Spitzer et al., RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED EVALUATION OF ORAL ONDANSETRON IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH FRACTIONATED TOTAL-BODY IRRADIATION, Journal of clinical oncology, 12(11), 1994, pp. 2432-2438
Authors:
SPITZER TR
PETERS C
ORTLIEB M
TEFFT MC
TORRISI J
CAHILL R
GADNER H
URBAN C
DEEG HJ
Citation: Tr. Spitzer et al., ETOPOSIDE IN COMBINATION WITH CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION OR BUSULFAN AS CONDITIONING FOR MARROW TRANSPLANTATION IN ADULTS AND CHILDREN, International journal of radiation oncology, biology, physics, 29(1), 1994, pp. 39-44
Authors:
FINBERG RW
MATTIA AR
ZERBEY AL
MARK EJ
FISHMAN JA
SPITZER TR
AMBROSINO D
Citation: Rw. Finberg et al., A 47-YEAR-OLD MAN WITH INGUINAL LYMPHADENOPATHY AND FEVER DURING PREPARATION FOR A BONE-MARROW TRANSPLANT - HERPES-SIMPLEX VIRUS TYPE-2 NECROTIZING LYMPHADENITIS, The New England journal of medicine, 331(25), 1994, pp. 1703-1709
Citation: Tj. Lynch et al., A 41-YEAR-OLD WOMAN WITH NEUROLOGIC ABNORMALITIES AND AN OSTEOLYTIC LESION IN THE MANDIBLE - BURKITTS-LYMPHOMA INVOLVING MANDIBLE, LYMPH-NODES, BONE-MARROW, (SPLEEN), AND QUESTIONABLE NERVOUS-SYSTEM, The New England journal of medicine, 331(2), 1994, pp. 107-113
Authors:
WILLERFORD DM
PREFFER F
MCAFEE S
SCAVONE M
SPITZER TR
Citation: Dm. Willerford et al., MOBILIZATION OF EARLY AND LATE HEMATOPOIETIC PRECURSORS USING GMCSF, GCSF, OR COMBINED GMCSF AND GCSF FOLLOWING CHEMOTHERAPY, Blood, 84(10), 1994, pp. 10000090-10000090
Citation: M. Cottlerfox et Tr. Spitzer, IMMUNOGLOBULIN PREPARATIONS, ACUTE GRAFT-VERSUS-HOST DISEASE, AND INFECTION AFTER MARROW TRANSPLANT, Lancet, 341(8860), 1993, pp. 1592-1592
Authors:
SMITH CV
SUZUKI T
GUZZETTA PC
NAKAJIMA K
SUNDT TM
MIXON A
SPITZER TR
ECKHAUS MA
SACHS DH
Citation: Cv. Smith et al., BONE-MARROW TRANSPLANTATION IN MINIATURE SWINE .4. DEVELOPMENT OF MYELOABLATIVE REGIMENS THAT ALLOW ENGRAFTMENT ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS, Transplantation, 56(3), 1993, pp. 541-549
Authors:
AREMAN EM
DICKERSON SA
KOTULA PL
SPITZER TR
SACHER RA
Citation: Em. Areman et al., USE OF A LICENSED ELECTROLYTE SOLUTION AS AN ALTERNATIVE TO TISSUE-CULTURE MEDIUM FOR BONE-MARROW COLLECTION, Transfusion, 33(7), 1993, pp. 562-566
Citation: Tr. Spitzer et al., A 49-YEAR-OLD MAN WITH MYELOFIBROSIS, MYELOID METAPLASIA, AND OSTEOLYTIC LESIONS OF THE LEFT FEMUR - GRANULOCYTIC SARCOMA INVOLVING BONE, SOFT-TISSUE, AND LYMPH-NODES, COMPLICATING MYELOFIBROSIS, WITH MYELOID METAPLASIA, The New England journal of medicine, 329(6), 1993, pp. 417-423